Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Dec 13, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000121.pdf 0001883850-22-000121.xls
Dec 13, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000122.pdf 0001883850-22-000122.xls
Dec 13, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000123.pdf 0001883850-22-000123.xls
Dec 12, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000107.pdf 0001883850-22-000107.xls
Dec 12, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000108.pdf 0001883850-22-000108.xls
Dec 02, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000102.pdf 0001883850-22-000102.xls
Dec 02, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000104.pdf 0001883850-22-000104.xls
Dec 02, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000103.pdf 0001883850-22-000103.xls
Nov 25, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000098.pdf 0001883850-22-000098.xls
Nov 16, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000096.pdf 0001883850-22-000096.xls

Data provided by Kaleidoscope.

Investors & Media